LOGO
LOGO

Temple-Inland acquires remaining stake in Premier Boxboard Limited joint venture for $62 Mln cash - Update

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Temple-Inland Inc. (TIN), a manufacturer of corrugated packaging and building products, announced on Friday that it has acquired the remaining fifty percent interest in Premier Boxboard Limited LLC from Caraustar Industries, Inc. (CSAR) for $62 million in cash and assumption of $25 million of debt.

Temple-Inland said that the transaction will be immediately accretive to its earnings, returns and cash flow. Further, it expects to realize synergies of approximately $10 million from reducing cost, improving productivity and optimizing the mix of product as the mill is fully integrated into the Temple-Inland mill system.

Premier Boxboard Limited LLC or PBL was a joint venture between Temple-Inland and Caraustar. It produces lightweight gypsum facing paper and containerboard at 308,000 tons per year mill in Newport, Indiana.

For the last three years, PBL's average annual EBITDA was $23 million, and for first quarter 2008 EBITDA was $7 million, Temple-Inland noted.

The Austin, Texas-based Temple-Inland noted that it will fund the cash portion of the purchase price through borrowings under its existing credit facilities.

TIN is trading up $0.64 or 4.84% at $13.85 on a volume of 446 thousand shares.

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

Latest Updates on COVID-19